Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination

Increase of Antibacterial Therapy Efficacy in Chronic Sepsis with Cycloferon and Reamberin Combination

The use of reamberin and cycloferon combination for increasing the antibacterial therapy efficacy in patients with chronic sepsis (CS) was studied. It was shown that the combination provided more rapid elimination of the CS exacerbation symptoms, normalization of the hematologic indices, bacteriemia...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. M. Frolov, N. A. Peresadin, R. B. Chkhetiany, O. V. Kruglova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	chronic sepsis pathogenesis antibacterial therapy cytokines cycloferon reamberin
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The influence of reamberin on oxygen balance, oxidative stress and lung dysfunction in patients with abdominal sepsis
by: A. B. Tolkach, et al.
Published: (2012-06-01)

Cycloferon Efficacy of Therapy of Chronic Hepatitis B (Results of Randomized Multicentre Study)
by: T. V. Sologub, et al.
Published: (2020-05-01)

Clinical Efficacy of Cycloferon in Complex Therapy of Infectious Mononucleosis in Pediatrics
by: E. B. Kasymova, et al.
Published: (2020-05-01)

Experimental and Clinicolaboratory Evaluation of Complex Therapy Efficacy in Arboviral Infections
by: M. G. Romatsov, et al.
Published: (2020-05-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Evaluation of Safety and Pharmacotherapeutic Efficacy of Cycloferon in Treatment of Astrakhan Rickettsial Fever
by: YU. V. Sherysheva, et al.
Published: (2020-05-01)

Cycloferon Therapy of Chronic Gastroduodenitis in Children
by: S. Yu. Yermak, et al.
Published: (2020-05-01)

Cycloferon as an Agents of Antirelpsing Therapy in Patients with Chronic Hyperplastic Sinusitis
by: I. P. Vasilenko, et al.
Published: (2020-05-01)

Monitoring of Side Effects and Estimation of Cycloferon Efficacy in Treatment of Children with Frequent and Prolonged Diseases
by: S. A. Lyalikov, et al.
Published: (2020-05-01)

When to start antibiotic therapy in patients with sepsis in the ICU?
by: V. A. Rudnov, et al.
Published: (2020-11-01)

Virus Infections and Interferon Inductors in the Complex Therapy
by: M. G. Romantsov, et al.
Published: (2020-05-01)

The role of cycloferon in the treatment of chronic Helicobacter pyloriinduced gastritis with gastric erosions associated with Epstein – Barr virus
by: T. E. Afanasenkova, et al.
Published: (2022-02-01)

The Clinical Course and Correction of Metabolic Disturbances in Patients with Severe Methadone Poisoning
by: B. V. Batotsyrenov, et al.
Published: (2013-04-01)

Intrauterine inflammation exposure may increase the risk of late-onset sepsis in premature infants: a retrospective cohort study
by: Xiafang Chen, et al.
Published: (2025-07-01)

Investigation of the drug «Cycloferon» influence on the morbidity of acute respiratory viral infections and flu and condition of local immunity in children of different age groups
by: Ye. I. Kondratieva, et al.
Published: (2006-06-01)

Up-to-Date Approach to Treatment of Inflammatory Infections in the Maxillofacial Region
by: M. G. Romantsov, et al.
Published: (2020-05-01)

EFFECTIVENESS OF REAMBERIN IN CORRECTION OF OXIDATIVE STRESS SYNDROME IN PATIENTS WITH PHLEGMONOUS AND GANGRENOUS ERYSIPELAS AGAINST THE BACKGROUND OF THE 2 TYPE DIABETES MELLITUS
by: I. I. Zeleny, et al.
Published: (2018-01-01)

Sepsis therapies: learning from 30 years of failure of translational research to propose new leads
by: Jean‐Marc Cavaillon, et al.
Published: (2020-03-01)

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)
by: V. V. Stelmakh, et al.
Published: (2020-05-01)

Aspects of the formation of encephalopathy and myocardiopathy in sepsis
by: M. V. Petrova, et al.
Published: (2023-10-01)

Research progress on the pathogenesis of acute lung injury in sepsis
by: WANG Qin，YU Xu，LI Qingying，LU Yibin
Published: (2025-08-01)

IMMUNOLOGICAL FEATURES OF SEPSIS PHENOTYPES AND ENDOTYPES
by: Mariia B. Potapova, et al.
Published: (2019-08-01)

Pathogenetic Therapy in Patients with Recurrent Herpetic Infection
by: A. R. SHOGENOVA, et al.
Published: (2022-09-01)

Metabolomic and cytokine profiles of high-risk sepsis phenotypes in children
by: Ryan R. Hurtado, et al.
Published: (2025-07-01)

Antibacterial therapy of sepsis in extracorporeal detoxication: current problems and ways to solve them
by: A. V. Marukhov, et al.
Published: (2020-12-01)

Lipid nanoparticles from L. meyenii Walp mitigate sepsis through multimodal protein corona formation
by: Junsik J. Sung, et al.
Published: (2025-06-01)

Combined Therapy of Patients with Recurring Anogenital Herpes Infection
by: M. R. Rakhmatulina
Published: (2020-05-01)

Ways of increase of tolerance of, and adherence to antibacterial therapy
by: A. V. Vorontsova, et al.
Published: (2021-06-01)

Redefining the role of IL-18 in post-surgical recovery and sepsis: a key mediator of inflammation resolution
by: Ioanna Papatheodorou, et al.
Published: (2025-07-01)

MYOCARDIAL DYSFUNCTION IN SEPSIS PATIENTS
by: L. L. Plotkin, et al.
Published: (2018-01-01)

ENDOGENOUS INTOxICATION AND SEPSIS
by: I. V. Aleksandrova, et al.
Published: (2016-02-01)

Immunological criteria for the diagnosis of multisystem inflammatory syndrome associated with MERS-COV-2 and infectious diseases with sepsis in children
by: Yu. E. Konstantinovа, et al.
Published: (2024-12-01)

PHARMACOLOGICAL PROPHYLAXIS OF REPERFUSION SYNDROME IN PATIENTS WITH SEVERE POLYTRAUMA ACCOMPANIED BY SHOCK
by: Yu. S. Polushin, et al.
Published: (2018-01-01)

Clinical guidelines «Sepsis (in adults)»
by: S. F. Bagnenko, et al.
Published: (2025-02-01)

Molecular mechanisms and functions of protein acetylation in sepsis and sepsis-associated organ dysfunction
by: Yang-Fan Xu, et al.
Published: (2025-07-01)

The effectiveness of biapenem in the treatment of sepsis
by: I. V. Shlyk, et al.
Published: (2024-04-01)

OPPORTUNITIES OF CORRECTION OF RHEOLOGICAL PROPERTIES OF BLOOD IN INTENSIVE THERAPY IN PATIENTS WITH PERITONITIS AND ACUTE BOWEL OBSTRUCTION
by: Yu. P. Orlov, et al.
Published: (2018-01-01)

The clinical significance of proadrenomedulin level in blood in sepsis patients
by: V. A. Rudnov, et al.
Published: (2019-11-01)

Relationship between Th1/ Th2 cytokines and severity of acute lung injury secondary to sepsis
by: FU Daoliang，CHEN Dejian，REN Lei，HOU Xiaolin
Published: (2025-08-01)

Scope of mean neutrophil volume as an indicator of neonatal sepsis
by: Chaitra B E, et al.
Published: (2022-09-01)